Resultats de la cerca - Tadamitsu Kishimoto

Refinar resultats
  1. 1
    Interleukin-6: discovery of a pleiotropic cytokine.

    Interleukin-6: discovery of a pleiotropic cytokine. per Tadamitsu Kishimoto

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The biology of interleukin-6

    The biology of interleukin-6 per Tadamitsu Kishimoto

    Publicat 1989
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology

    INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology per Tadamitsu Kishimoto

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    The biology of interleukin-6

    The biology of interleukin-6 per Tadamitsu Kishimoto

    Publicat 1989
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Cytokine receptors and signal transduction

    Cytokine receptors and signal transduction per Tetsuya Taga, Tadamitsu Kishimoto

    Publicat 1992
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases

    Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases per Toshio Tanaka, Tadamitsu Kishimoto

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders

    A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders per David Millrine, Tadamitsu Kishimoto

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    The Two-Faced Cytokine IL-6 in Host Defense and Diseases

    The Two-Faced Cytokine IL-6 in Host Defense and Diseases per Masashi Narazaki, Tadamitsu Kishimoto

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

    Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms per Sujin Kang, Tadamitsu Kishimoto

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19

    IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19 per Tadamitsu Kishimoto, Sujin Kang

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Current status and prospects of IL-6–targeting therapy

    Current status and prospects of IL-6–targeting therapy per Masashi Narazaki, Tadamitsu Kishimoto

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Regulation of Antibody Response in Vitro

    Regulation of Antibody Response in Vitro per Tadamitsu Kishimoto, Kimishige Ishizaka

    Publicat 1973
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Regulation of Antibody Response in Vitro

    Regulation of Antibody Response in Vitro per Tadamitsu Kishimoto, Kimishige Ishizaka

    Publicat 1973
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    The paradigm of IL-6: from basic science to medicine.

    The paradigm of IL-6: from basic science to medicine. per Tetsuji Naka, Norihiro Nishimoto, Tadamitsu Kishimoto

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6.

    A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. per Shigemi Kinoshita, Shizuo Akira, Tadamitsu Kishimoto

    Publicat 1992
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells

    IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells per Akihiro Kimura, Tetsuji Naka, Tadamitsu Kishimoto

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis

    Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis per Shumpei Yokota, Toshio Tanaka, Tadamitsu Kishimoto

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

    Molecular cloning and structure of a pre-B-cell growth-stimulating factor. per Takashi Nagasawa, Hitoshi Kikutani, Tadamitsu Kishimoto

    Publicat 1994
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

    Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases per Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Interleukin (IL-6) Immunotherapy

    Interleukin (IL-6) Immunotherapy per Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: